Pharmacokinetic modelling as a tool to assess TB treatment adherence: application to the REMEMBER study
Poor adherence may have contributed to TB incidence in REMEMBER. While not definitive, personalised thresholds from model-based simulations remain useful for adherence assessment.
Authors
- W.P. Samaneka
- P. Severe
- VG Veloso
- M.C. Hosseinipour
- J. Kumwenda
- L. Mohapi
- A. Naidoo
- P. Denti
- M. Nyirenda
- A. Gupta
- V. Mave
- J. Valencia
- N. Mwelase
- M. Chirehwa
- C. Kanyama
- N. Abdelgawad
- K. Scarsi
- H. McIlleron
Institutions
- University of North Carolina at Chapel Hill (US)
- Nebraska Medical Center (US)
- Johns Hopkins University (US)
- University of Zimbabwe (ZW)
- University of Cape Town (ZA)
- University of the Witwatersrand (ZA)
- Asociación Civil Impacta Salud y Educación (PE)
- Johns Hopkins Medicine (US)
- Centre for the AIDS Programme of Research in South Africa (ZA)
- Kamuzu Central Hospital (MW)
- Instituto Evandro Chagas (BR)
- Perinatal HIV Research Unit (ZA)
- Government Medical College (IN)
- Kamuzu University of Health Sciences (MW)
- Fundação Oswaldo Cruz (BR)
- University of Nebraska Medical Center (US)
Publication Details
- Journal
- IJTLD OPEN
- Published
- 2026-02-01
- DOI
- https://doi.org/10.5588/ijtldopen.25.0467
- Primary Topic
- Tuberculosis Research and Epidemiology
- Type
- article
- Field-Weighted Citation Impact
- 0.00